Skip to content

13D/A filed by Sermonix Pharmaceuticals, Inc.

Sermonix Pharmaceuticals, Inc. and 1 other reporting person reported 3,149,470 LONA shares, 25.1% of the class, as of 2026-10-26, in a 13D/A accepted by EDGAR 2026-10-28 19:37:30 UTC.

Accession
0001655566-26-000004
Filer
CIK 1655566
Filed
2026-10-28
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Stake

Shares
3,149,470
Percent of class
25.1%
Event date
2026-10-26

How the shares relate across the reporting persons: every reporting person reports the same shares (a chain of control). The page shows the largest row.

Read for the filer group Sermonix Pharmaceuticals, Inc..

Reporting persons

PersonTypeSole votingShared votingSole dispositiveShared dispositiveAggregatePercent
Sermonix Pharmaceuticals, Inc.CO03,149,47003,149,4703,149,47025.1%
Portman David J.IN03,149,47003,149,4703,149,47025.1%